PRESS RELEASE:Â 4 May 2022, 07:00 CEST New Study Led by Memorial Sloan Kettering Cancer Center (NY, US)Â Shows Idyllaâ„¢ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Compared to...
Atara Biotherapeutics, an immunology-focused biopharmaceutical company based in San Francisco, announced a fatal serious adverse event (SAE) with a patient in a clinical trial at Memorial Sloan Kettering Cancer Center (MSK).
AIRPORT CITY, Israel, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Biosight Ltd., a pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, today announced the initiation of a Phase 2 trial to evaluate aspacytarabine (BST-236), Biosight’s proprietary antimetabolite, as a second line treatment for patients with relapsed or refractory myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The multi-center study will be conducted across 18 leading U.S. and Israeli sites including Memorial Sloan Kettering Cancer Center and The University of Texas MD Anderson Cancer Center.
KIRKLAND, Wash.--(BUSINESS WIRE)-- Prevencio, Inc. today announces the presentation of data demonstrating that its Artificial Intelligence (AI) driven HART CVE blood test scores strongly correlate with subsequent adverse cardiac events in lung cancer patients undergoing radiation treatment. Researchers and clinicians from Memorial Sloan Kettering Cancer Center collaborated to test their lung cancer population.
Bluebird bio was hit with a patent infringement lawsuit last week from a Chicago-based biotech it has had an ongoing beef with calling for $2 billion to help cure the “irreparable harm” caused by alleged willful infringement.nBluebird bio is facing a lawsuit from Errant Gene Therapeutics for violating patent law in two instances, the company says.
A portion of Memorial Sloan Kettering Cancer Center’s Oncology Knowledge Base (OnkoKB) received the recognition under FDA’s database recognition program. In April 2018, the agency finalized a guidance document that sets a roadmap for how developers of genetic and genomic-base in vitro diagnostics (IVDs) can use public databases of human genetic variants in support of clinical validity claims.
Memorial Sloan Kettering Cancer Center, the world’s oldest and largest private cancer center, has launched MSKCC India, its latest expansion in Asia at a time of rising demand for healthcare service in the region.